| scholarly article | Q13442814 |
| P50 | author | Jennifer K Quint | Q44802756 |
| Hana Müllerová | Q58165569 | ||
| P2093 | author name string | Adam Hawkins | |
| Amit Shukla | |||
| P2860 | cites work | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 |
| Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease | Q27000043 | ||
| Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD) | Q28680747 | ||
| Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource | Q30840122 | ||
| Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial | Q35120004 | ||
| COPD exacerbations: definitions and classifications. | Q35149042 | ||
| The clinical features of the overlap between COPD and asthma | Q35477522 | ||
| The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly | Q35494872 | ||
| Recent trends in physician diagnosed COPD in women and men in the UK. | Q35534024 | ||
| The general practice research database: role in pharmacovigilance | Q35887415 | ||
| COPD exacerbations .1: Epidemiology | Q36183861 | ||
| The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population | Q36835097 | ||
| Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface | Q37598942 | ||
| Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects | Q37671448 | ||
| Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS. | Q38109910 | ||
| Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality | Q39642057 | ||
| Prevalence, severity and underdiagnosis of COPD in the primary care setting | Q43834961 | ||
| Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease | Q44780422 | ||
| Increased risk of myocardial infarction and stroke following exacerbation of COPD. | Q46731950 | ||
| Patterns of comorbidities in newly diagnosed COPD and asthma in primary care | Q47706912 | ||
| Airway and systemic inflammation and decline in lung function in patients with COPD. | Q47707074 | ||
| Development of the i-BODE: validation of the incremental shuttle walking test within the BODE index. | Q50510542 | ||
| Changes in forced expiratory volume in 1 second over time in COPD. | Q51521679 | ||
| Time course and pattern of COPD exacerbation onset. | Q53792098 | ||
| The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. | Q55485607 | ||
| Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease | Q57955820 | ||
| Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease | Q62111232 | ||
| Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study | Q84254729 | ||
| Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary | Q84976709 | ||
| P433 | issue | 12 | |
| P304 | page(s) | e006171 | |
| P577 | publication date | 2014-12-18 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study | |
| P478 | volume | 4 |
| Q40232295 | A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. |
| Q91842783 | Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality |
| Q92533368 | CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition |
| Q36776335 | COPD exacerbations by disease severity in England |
| Q40484450 | Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation |
| Q64107336 | Clinical burden of illness among patients with severe eosinophilic COPD |
| Q55262565 | Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong – computerized data collection and analysis. |
| Q37158368 | Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients |
| Q47108348 | Determinants of exacerbation risk in patients with COPD in the TIOSPIR study |
| Q61806930 | Effectiveness trials: critical data to help understand how respiratory medicines really work? |
| Q55413850 | Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission. |
| Q55003635 | Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data. |
| Q64080562 | Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis |
| Q90588230 | Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD |
| Q36826833 | Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database. |
| Q90594380 | Inaccurate diagnosis of COPD: the Welsh National COPD Audit |
| Q57146487 | Increased Risk of Exacerbation in Asthma Predominant Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome |
| Q37240857 | Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study |
| Q92595453 | Management of chronic obstructive pulmonary disease: A review focusing on exacerbations |
| Q94525568 | Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach |
| Q52688481 | Natural History of COPD Exacerbations in a General Practice Based COPD Population. |
| Q36557662 | No association between exacerbation frequency and stroke in patients with COPD. |
| Q90621898 | Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD) |
| Q90247163 | Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
| Q40450026 | Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease. |
| Q89975804 | Physical, Psychological, and Social Factors Associated with Exacerbation-Related Hospitalization in Patients with COPD |
| Q31028327 | Predicting frequent COPD exacerbations using primary care data |
| Q38823010 | Prediction and prevention of exacerbations and mortality in patients with COPD. |
| Q47139198 | Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. |
| Q61799377 | Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort |
| Q91665443 | Primary care risk stratification in COPD using routinely collected data: a secondary data analysis |
| Q28596796 | Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant? |
| Q49217167 | Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned |
| Q38881287 | Reframing the association and significance of co-morbidities in heart failure |
| Q40062038 | Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom |
| Q39419429 | Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial |
| Q36403690 | Spatial Clustering and Local Risk Factors of Chronic Obstructive Pulmonary Disease (COPD). |
| Q52564986 | Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study. |
| Q35951223 | Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records |
| Q90597634 | Web-based support for self-management strategies versus usual care for people with COPD in primary healthcare: a protocol for a randomised, 12-month, parallel-group pragmatic trial |
| Q93219507 | [Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers] |
Search more.